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Cellular injurycausesamyriadofprocesses thataffect
proteostasis.We describe nucleocytoplasmic coagu-
lation (NCC), an intracellular disulfide-dependent
protein crosslinking event occurring upon late-stage
cell death that orchestrates the proteolytic removal
of misfolded proteins. In vitro and in vivo models of
neuronal injury show that NCC involves conversion
of soluble intracellular proteins, including tubulin,
into insoluble oligomers. These oligomers, also
seen in human brain tissue following neurotrauma,
act as a cofactor and substrate for the plasminogen-
activating system. In plasminogen/ mice, levels of
misfolded b-tubulin were elevated and its clearance
delayed following neurotrauma, demonstrating a
requirement for plasminogen in the removal of NCC
constituents. While additional in vivo studies will
further dissect this phenomenon, our study clearly
shows that NCC, a process analogous to the forma-
tionof thrombi, generatesanaggregatedprotein scaf-
fold that limits release of cellular components and
recruits clearance mechanisms to the site of injury.
INTRODUCTION
Tissue injury and repair necessitates the coordinated and timely
removal of dead or dying cells and their intracellular compo-
nents. However, during conditions of large-scale stress, for
example, in response to ischemia or trauma, protein homeo-
stasis can be compromised resulting in the accumulation of
misfolded proteins. The nature of protein aggregation and the
proteolytic mechanisms that remove the misfolded protein
burden following acute injury are poorly understood.
The plasminogen activating system is known for its involve-
ment in the proteolytic turnover of proteins, mostly in relationCto blood clot removal and remodeling of the extracellular matrix
but more recently in the breakdown of misfolded proteins.
Tissue-type plasminogen activator (tPA) is an extracellular serine
protease that cleaves plasminogen into plasmin, a potent
trypsin-like protease with broad substrate specificity. tPA
possesses a conserved amino-terminal domain cluster that not
only binds specifically to fibrin within blood clots, but also to
b-amyloid and other misfolded proteins (Kranenburg et al.,
2002; Longstaff et al., 2011; Maas et al., 2008). For tPA to
generate relevant levels of plasmin, it needs to colocalize with
plasminogen on the substrate surface. Hence, the ultimate target
is also a necessary cofactor for plasmin formation. The classic
example of a cofactor/substrate for tPA is fibrin—the proteina-
ceous scaffold of thrombi. Misfolded proteins have also been
identified as potent cofactors that promote tPA-mediated
plasmin formation (Kingston et al., 1995; Kranenburg et al.,
2002; Radcliffe and Heinze, 1981), and, like fibrin, initiate their
own proteolytic degradation.
We recently demonstrated that during the process of cell
injury, a cofactor was generated within cells that bound both
tPA and plasminogen and enhanced tPA-mediated plasminogen
activation (Samson et al., 2009). This cofactor activity correlated
with the accumulation of detergent-insoluble proteins (Samson
et al., 2009). Therefore, we hypothesized that cell injury triggers
the formation of a misfolded protein cofactor for tPA, and that
loss of tPA-mediated plasmin formation would lead to the accu-
mulation of misfolded proteins in vivo following injury.
In the current study, we identify a number of intracellular
proteins that misfold and aggregate in a uniquemanner following
cell injury. We have named this injury-induced misfolding event
‘‘nucleocytoplasmic coagulation’’ or NCC. NCC occurs following
diverse forms of cellular injury and was observed in vitro, and
also in vivo following traumatic brain injury in mice and
humans. In contrast to other well-characterized forms of protein
aggregation, a hallmark of NCC was the presence of extensive
intermolecular disulfide crosslinking. This disulfide crosslinking
was a cell-wide event that resulted in the entrapment of in-
tracellular constituents. NCC aggregates were then shown toell Reports 2, 889–901, October 25, 2012 ª2012 The Authors 889
Figure 1. Numerous Intracellular Proteins Aggregate following Acute Injury
(A) Coomassie-stained reduced SDS-PAGE of Triton-soluble and Triton-insoluble fractions from 48 hr glutamate-injured neuronal cultures. Dark arrowheads
indicate mass spectrometry-identified species that lose detergent solubility upon injury. White arrowheads indicate unidentified less abundant species that also
lose detergent solubility upon injury.
(B andC) Neuronal cultures were injured with glutamate, staurosporine or MG132. Plasmamembrane integrity (B; n = 3) and cell metabolism (C; n = 4) parameters
were measured at various time points. Data are mean ± SEM. **p < 0.01 and ***p < 0.001 relative to uninjured cultures determined by two-way ANOVA with
Bonferroni correction.
(D) Representative immunoblots of reduced SDS-PAGE confirming that the mass spectrometry-identified proteins lose solubility following 48 hr glutamate,
staurosporine, and MG132 injury in neuronal culture.
(E) Representative immunoblots of reduced SDS-PAGE confirming that the mass spectrometry-identified proteins lose solubility following 24 hr staurosporine-
injury in human lymphocyte (Jurkat) culture.
See also Figure S1 and Table S1.become exposed to the extracellular space to allow binding of
tPA and plasminogen, resulting in plasmin-mediated clearance
of dead cell debris. In support of this cascade of events, we
show that NCC-generated misfolded proteins are more abun-
dant and have significantly delayed clearance following brain
injury in the absence of plasminogen.
Thus, NCC involves the temporally coordinated and rapid
covalent crosslinking of soluble proteins into an insolublemacro-
molecular aggregate that is amenable to physiological clear-
ance. A primary consequence of NCC is to trap and limit release
of intracellular constituents. A secondary consequence is the
generation of a scaffold that recruits and activates extracellular
clearance mechanisms. NCC therefore follows the same princi-
pals as traditional blood coagulation, which first prevents blood
loss and subsequently recruits enzymes to allow targeted prote-
olysis. Hence, analogous biological processes are used for the
removal of thrombi and protein aggregates that form upon cell
death.
RESULTS
Identification of Proteins that Aggregate upon
End-Stage Cell Death
Our prior studies suggested that a large-scale protein aggrega-
tion event occurs following cell injury (Samson et al., 2009). To890 Cell Reports 2, 889–901, October 25, 2012 ª2012 The Authorsidentify what proteins aggregate upon acute injury, we harvested
detergent-soluble and -insoluble fractions from uninjured or
glutamate-injured primarymousecortical neurons. Peptidemass
fingerprinting identified numerous intracellular proteins that lose
detergent solubility upon injury, including heat shock protein
90b (HSP90b), a- and b-tubulin, b-actin, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (Figure 1A and Table S1).
In neuronal culture, glutamate triggers fast-acting receptor-
mediated necrosis of neurons, whereas staurosporine elicits
slower acting apoptosis of neurons and glia (Figures 1B and
1C; data not shown) (Samson et al., 2008, 2009). In contrast,
MG132 induces a unique form of cell death caused by accumu-
lation of insoluble ubiquitinylated proteins (Figure 1D). Despite
exhibiting different temporal profiles, potencies, and modes of
action, all agonists caused HSP90b, a-, and b-tubulin and
GAPDH to lose solubility (Figure 1D). The same nucleocytoplas-
mic proteins aggregate following staurosporine-induced injury of
human lymphocytes (Figures 1E and S1), thereby showing that
this effect is not specific to neurons.
We next studied the time course of protein aggregation in
response to staurosporine treatment in cultures of primary
neurons. Although the identified proteins all began to lose solu-
bility within the first few hours of staurosporine exposure (Fig-
ure 2A), significant loss of solubility only occurred at 24 hr after
injury (Figure S1). Therefore, the identified proteins do not
aggregate during the initial stages of cell injury, but rather upon
end-stage cell death, when plasma membrane disruption has
allowed release of lactate dehydrogenase (Figure 1B) and
when cells were metabolically defunct (Figure 1C). Similarly,
staurosporine treatment of lymphocytes showed that the aggre-
gation of intracellular proteins correlated with a loss of plasma
membrane integrity (Figure S1).
Therefore, aggregation of numerous intracellular proteins is
a generic response to cell death that occurs across diverse cell
types and occurs regardless of the cause of cell death.
Disulfide Crosslinking and Aggregation of Intracellular
Proteins upon End-Stage Cell Death
Cell death-induced aggregation of HSP90b, a- and b-tubulin,
b-actin, and GAPDH did not coincide with a discernible shift
in electrophoretic mobility through reduced sodium dodecyl
sulfate (SDS)-containing gels (Figures 1D, 1E, and 2A), suggest-
ing that injury did not cause extensive glycation, hyperphosphor-
ylation, or other post-translational modifications that signifi-
cantly affect their electrophoretic migration. Rather, for each of
the identified proteins, injury-induced loss of monomer solubility
seen under reducing conditions (Figure 2A, asterisks) correlated
with the formation of high molecular weight (HMW) species
under nonreducing conditions in neuronal culture. These HMW
species were stable during boiling in 2% SDS-loading buffer
and were trapped either at the stacking gel interface or at the
top of nonreduced SDS-containing gels (Figure 2A, arrowheads).
Immunoreactivity toward the trapped HMW species of HSP90b,
tubulin, actin, and GAPDH was confirmed using at least two
different primary antibodies for each target, and no immunoreac-
tivity toward HMW species was noted when membranes were
probed in the absence of primary antibodies (data not shown).
Formation of the same dithiothreitol (DTT)-sensitive HMW
species was also observed following glutamate, etoposide, or
MG132 injury in neuronal culture (data not shown). Formation
of the same DTT-sensitive HMW species was also observed
following staurosporine injury in human lymphocytes (data not
shown). These observations suggest that HSP90b, tubulin, actin,
and GAPDH all lose solubility upon injury in culture via intermo-
lecular disulfide crosslinking into HMW species.
A similar protein aggregation response was observed in vivo
using a mouse model of traumatic brain injury (TBI), with
more insoluble HSP90b, b-tubulin, and GAPDH detected in the
ipsilateral cortex, relative to the contralateral cortex (Figure 2B).
More HMW tubulin and GAPDH (and to a lesser extent actin; Fig-
ure S2B) were also observed in the ipsilateral cortex relative to
the contralateral cortex under nonreducing conditions (Fig-
ure 2B). These HMW species were all completely reduced to
monomeric weight by DTT (Figure S2B).
Consistent with our in vivo mouse TBI data, a strong positive
correlation between the amount of detergent-insoluble b-tubulin
and GAPDH versus postmortem interval (PMI) was observed in
brain tissue from human TBI patients (Figure 2C), whereas no
correlation was observed in brain tissue from non-TBI control
patients (Figure 2D). Similarly, a nonsignificant positive cor-
relation between insoluble HSP90b versus PMI was observed
in brain tissue from human TBI patients (Figure 2C), whereas
no increasing trend was observed in brain tissue from non-CTBI control patients (Figure 2D). No increase in the amount of
detergent-insoluble actin with PMI was observed in brain
samples from either TBI or non-TBI control patients (Figures
2C and 2D). Therefore, analysis of human brain samples con-
firmed that tubulin, GAPDH and HSP90b, but not actin, aggre-
gate following TBI.
Some differences in injury-induced aggregation were noted
between our cell culture and in vivo mouse and human experi-
ments. In particular, whereas actin became detergent-insoluble
upon injury in culture (Figure 2A), it failed to readily accumulate
into an insoluble form following injury in vivo (Figures 2B
and 2C). Moreover, no HMW species for HSP90bwere detected
in our in vivo experiments (Figure 2B). The basis for these
discrepancies is being further evaluated.
Next, we adapted a cysteine thiol staining protocol commonly
used for proteins in solution, to visualize disulfide-bonded struc-
tures in situ following cellular injury. As shown in Figure 3A, in
contrast to uninjured cultures, treatment of neuronal cultures
with glutamate, staurosporine or MG132 produced morphologi-
cally distinct dead cell populations that all stained strongly for
disulfide bonded proteins. Regardless of the mode of injury,
two disulfide-rich dead cell structures were apparent: (1)
‘‘spheroids’’ (open arrowheads in Figure 3A) that were spread
throughout the neuritic network, and (2) ‘‘somatic corpses’’ that
encapsulated thenonviablenucleocytoplasmic space (Figure3A,
arrows in top panels). These samedisulfide-rich somatic corpses
and spheroids could be observed in vivo following TBI exclu-
sively within the ipsilateral cortex (Figures 3B and S3; Movie S1).
Collectively, our data show that end-stage cell death coin-
cides with the conversion of numerous soluble intracellular
proteins into disulfide-crosslinked HMW detergent-insoluble
species within the nonviable cell soma and axodendritic struc-
tures. We hereafter refer to this unique form of protein aggrega-
tion as ‘‘nucleocytoplasmic coagulation’’ or NCC.
NCC Drives Nonamyloid Misfolding of Tubulin
We chose to focus on tubulin as a model to investigate NCC in
further detail. In order to observe the real-time formation of
dead cell structures, we transfected primary neurons with red
fluorescent protein-tagged b5-tubulin (tubulin-RFP) and tracked
fluorescence during staurosporine exposure (Figure 4A). In-
itially, tubulin-RFP occupied a normal cytoskeletal/cytoplasmic
location (Figure 4A, arrow at 0 and 2 hr); however, as injury pro-
gressed tubulin-RFP relocated and became deposited into
somatic corpses (Figure 4A, arrow atR4 hr) and spheroids (Fig-
ure 4A, arrowheads).
Movies S2, S3, and S4 shows representative experiments of
tubulin-RFP-transfected neurons under uninjured conditions
and under glutamate or staurosporine challenge. From these
experiments, it was apparent that formation of corpses coin-
cided with a collapse of nuclear membrane integrity (visualized
by the sudden entry of tubulin-RFP into the nuclear compart-
ment) and a subsequent loss of plasma membrane integrity
(evident under bright-field microscopy; Movies S3 and S4). It
was also observed that the development of the dead cell struc-
tures was variable in timing, appearing as early as 20 min
following injury initiation and also developing over the ensuing
1–8 hr after treatment. Once somatic corpses were formedell Reports 2, 889–901, October 25, 2012 ª2012 The Authors 891
Figure 2. Death-Induced Aggregation Occurs via Intense Disulfide Crosslinking
(A and B) Representative immunoblots of Triton-soluble and Triton-insoluble fractions from (A) staurosporine-treated neuronal cultures and (B) ipsilateral (ipsi)
versus contralateral (contra) cerebral cortex of mice following unilateral traumatic brain injury (TBI). Asterisks indicate monomers of each identified proteins.
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Figure 3. Dead Cells Are Sites of Intense Disulfide Bonding
(A) Neuronal cell cultures 48 hr after injury were stained with Hoechst (nuclear stain) and Alexa Fluor 595-maleimide (cysteine thiol-reactive dye). Closed
arrowheads indicate viable cells with normal nuclear morphology. Arrows indicate somatic corpses with condensed (from glutamate), fragmented (from
staurosporine) or mixed (fromMG132) nuclear morphology. Open arrowheads indicate spheroids. Viable cells exhibit background staining withmaleimide with or
without DTT treatment. Somatic corpses and spheroids stain strongly with maleimide only after DTT-treatment. Micrographs are maximum projections of
confocal xyz stacks. Scale bar, 10 mm.
(B) Ipsilateral cortex 24 hr post-TBI was Alexa Fluor 488-maleimide-stained and imaged via multiphoton microscopy. Left micrograph is a maximum projection of
a xyz stack, with x dimension along the horizontal axis and z dimension along the vertical axis. Rightmicrograph is a single xy section taken from the part of the xyz
stack indicated by the arrowhead. x dimension is along the horizontal and y dimension is along the vertical axis. Scale bars, 50 mm.
See also Figure S3 and Movie S1.they were relatively immobile and stable in fluorescent signal
intensity. By comparison, spheroids often changed in size,
shape, and location within the first few hours following genesis.
A proportion of spheroids were degraded or dispersed shortly
after formation (Movies S3 and S4). The remaining populationArrowheads indicate dithiothreitol (DTT)-sensitive HMW species. Hash symbol in
antibodies.
(C and D) Percentage of Triton-insoluble protein (relative to total amount of same
TBI control patients (n = 9). Correlation coefficient (r values) and p values determ
between percentage insolubility and postmortem interval was observed for the t
See also Figure S2 and Table S2.
Cof spheroids appeared to be stable and persistent (Figure 4A,
arrowheads).
Immunofluorescence with b-tubulin-specific monoclonal
antibodies ‘‘D66’’ (Figure 4B) or ‘‘AA2’’ (data not shown)
confirmed that endogenous tubulin relocates from a normaldicates lower molecular species that were consistently detected by HSP90b
protein) in postmortem brain tissue from neurotrauma cases (n = 10; C) or non-
ined by two-tailed Pearson correlation test. No significant positive correlation
ested proteins within uninjured brain tissue from non-TBI control patients.
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Figure 4. Tubulin Misfolds during Acute Neuronal Injury
(A) Time lapse of tubulin-RFP fluorescence during staurosporine exposure. Closed arrowheads show the formation of spheroids during injury. Arrows indicate
a somatic corpse that forms 4–6 hr after injury.
(B) Immunofluorescence of 72 hr-injured neuronal cultures costained with D66 and 9F3 anti-b-tubulin antibodies. Arrowheads show spheroids that immunostain
for D66 but not 9F3. Arrows show somatic corpses that stain for D66 but not 9F3.
(C) Micrograph of 72 hr glutamate-injured cultures. Arrows show a somatic corpse that costains for tubulin and maleimide. Closed arrowheads show spheroids
that costain for tubulin and maleimide. Open arrowheads show spheroids that stain for maleimide but not for tubulin.
(D) Native immunofluorescence for tubulin and I11-reactive prefibrillar oligomeric structures on 48 hr glutamate-injured cultures. Arrows show dead cell corpses.
Open arrowheads show spheroids that stain for tubulin and I11 antibodies. Closed arrowheads show spheroids that stain for I11, but not for tubulin. Micrographs
in (B)–(D) are maximum projections of confocal xyz stacks.
Scale bars, 20 mm. See also Figure S4 and Movies S2, S3, and S4.
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cytoplasmic/cytoskeletal location into corpses and spheroids
upon injury. Tubulin deposited into corpses and spheroids
stained strongly for the presence of disulfide-bonded proteins
(Figure 4C). It is important to note that only a fraction of all
the disulfide-crosslinked structures were tubulin-positive,
confirming that numerous other proteins also undergo NCC
(Figure 4C). For instance, dramatic relocation/deposition of
a-tubulin, HSP90b and b-actin into spheroids and somatic
corpses was also observed upon neuronal cell death in culture
(Figure S4A).
We next utilized antibodies to investigate whether tubulin
within corpses and spheroids had lost its native structure. The
‘‘D66’’ antibody recognizes the carboxy-terminus of b-tubulin,
whereas the ‘‘9F3’’ antibody recognizes a sequence between
a helix 1 and b sheet 2 of b-tubulin (Lo¨we et al., 2001). Both these
epitopes are normally surfaced exposed, and situated on oppo-
site sides of the native a:b-tubulin dimer (Lo¨we et al., 2001) and
on opposite faces of the assembled microtubule (Sui and
Downing, 2010). Importantly, both epitopes are devoid of nearby
cysteine residues. Our immunofluorescence experiments show
that 9F3 and D66 antibodies costained all tubulin structures in
uninjured cultures, consistent with both 9F3- and D66-reactive
epitopes being surface exposed. In contrast, while tubulin spher-
oids and corpses remained highly reactive toward the D66 anti-
body, the 9F3 antibody demonstrated little-to-no reactivity
toward dead cell structures indicative of a conformational
change (Figure 4B).
We next sought to investigate the aggregation status of tubulin
within the dead cell structures. For this, we made use of the fact
that NCC coincides with a loss of membrane integrity by adding
tubulin-specific (D66) and conformation-specific (I11, OC, and
LOC; Kayed et al., 2007) antibodies directly to the bathing media
of cultures; thereby allowing antigen recognition under native
conditions. We found that spheroids and somatic corpses
were recognized by the ‘‘I11’’ antibody (Figure S4B), a well-
characterized antibody specific for prefibrillar oligomeric species
(Kayed et al., 2007). Moreover, a high degree of dead cell I11-
positive structures colocalized with D66 reactivity (Figure 4D).
Notably, D66-negative I11-positive dead cell structures were
also evident, further demonstrating that other proteins undergo
NCC. No reactivity toward the fibril-specific ‘‘OC’’ or ‘‘LOC’’ anti-
bodies was observed in cell culture (Figure S4B), indicating that
the aggregates within the dead cells are in a nonfibrillar
conformation.
In Vitro Aggregation of Purified Tubulin Recapitulates
NCC
Our cell culture and in vivo data suggest that tubulin was capable
of aggregation. To determine whether the misfolding of tubulin
was a self-association event, we examined the aggregation
tendencies of purified tubulin in vitro. Soluble native tubulin
naturally formed HMW DTT-sensitive detergent-insoluble
species when incubated at 37C in physiological buffer (Fig-
ure 5A). Treatment of tubulin with the free radical stressors,
hydrogen peroxide (Figure 5A) or NOR-3 (data not shown),
dramatically accelerated conversion into HMW disulfide-cross-
linked insoluble species, suggesting that tubulin was sensitive
to free radical-driven aggregation. Furthermore, consistentCwith our cell culture data (Figure 4B), in vitro-aggregated tubulin
was nonnative in structure as it maintained reactivity toward the
D66 antibody, but exhibited reduced reactivity toward the 9F3
antibody (Figure 5B). Last, transmission electron microscopy
showed that purified tubulin aggregates were amorphous in
morphology (Figure 5C). Collectively, native purified tubulin
was found to readily self-associate in vitro into a misfolded olig-
omer that exhibited many of the features of NCC in culture.
tPA Facilitates Clearance of NCC-Aggregated Tubulin
We have previously hypothesized that tPA mediates proteolytic
clearance of dead cells (Samson et al., 2009). Accordingly, we
sought to determine whether aggregated tubulin within corpses
and spheroids binds tPA and acts as a cofactor/substrate for
tPA-mediated plasmin formation. Figure 6A shows that exoge-
nously added Alexa Fluor 555-conjugated tPA (tPA555) rapidly
becomes internalized into endocytic vesicles in uninjured
cultures (as previously described; Ferna´ndez-Monreal et al.,
2004). By contrast, exogenous tPA555 binds almost exclusively
to dead cell corpses and spheroids in staurosporine- or MG132-
injured cultures. A mixture of tPA555 internalization and binding
to corpses/spheroids was observed in glutamate-injured
cultures due to the fact that glutamate injury is neuron-specific
and viable glia are endocytic. A high degree of colocalization
between the binding of tPA555 and tubulin-specific D66 anti-
body was observed on dead cell structures regardless of injury
(Figure 6A), consistent with the notion that misfolded tubulin
within spheroids and corpses is a cofactor for tPA-mediated
plasminogen activation.
To further test the hypothesis that misfolded tubulin is
a cofactor for tPA, we added tPA to uninjured and injured
cultures for 15 min, and then the conditioned media was re-
placed with media containing plasminogen. Plasmin generation
was then allowed to proceed for 1 hr before detergent-soluble
and -insoluble fractions were prepared in the presence of excess
plasmin inhibitors. It was predicted that cofactor molecules that
bind both tPA and plasminogen will promote their own plasmin-
mediated degradation. Indeed, immunoblot analysis shows that
plasmin generation on injured cultures resulted in a significant
decrease in insoluble tubulin (Figure 6B). Quantitative immuno-
blot analysis showed that plasmin generation had an insignifi-
cant effect on the presence of insoluble tubulin from uninjured
cultures (reduced by 17.7% ± 10.3%; p = 0.2), but profoundly
reduced insoluble tubulin levels from glutamate- and staurospor-
ine-injured cultures by 47.8% ± 8.1% (p = 0.01) and 93.0% ±
4.8%, (p = 0.003), respectively (n = 4 experiments; mean ±
SEM; two-tailed t test). Immunofluorescence on cultures also
showed that the size of tubulin-positive spheroids was reduced
following 1 hr of tPA-mediated plasmin formation (data not
shown). Therefore, tubulin deposited as a result of NCC acts
as both a cofactor and substrate for tPA-mediated plasmin
formation.
In support of this concept, we also found that in vitro-
aggregated tubulin accelerated tPA-mediated plasmin formation
significantly more than soluble native tubulin (Figures 6C and
S5A). Similarly, in vitro-aggregated tubulin, but not native tubulin,
was susceptible to tPA-mediated degradation in vitro (Figures
6D and S5B).ell Reports 2, 889–901, October 25, 2012 ª2012 The Authors 895
Figure 5. In Vitro Tubulin Aggregation
Mimics NCC
(A) Representative immunoblot of nonreduced
SDS-PAGE with D66 anti-b-tubulin antibody.
Purified tubulin converts from monomeric weight
(asterisk) to HMW DTT-sensitive detergent-insol-
uble species (arrowheads) upon control aggrega-
tion via incubation at 37C in physiological buffer,
and more rapidly upon incubation with H2O2 or
NOR-3 (data not shown). Addition of DTT to tubulin
that had been previously aggregated for 72 hr fully
reduced HMW species to monomeric weight.
Note: aggregation led to the generalized loss of
total protein amount (also evident in dot blot
experiments in B).
(B) Representative dot blot showing that aggre-
gation of purified tubulin in vitro causes preferen-
tial loss of reactivity toward the anti-b-tubulin 9F3
antibody, relative to the anti-b-tubulin D66 anti-
body. Quantitation of n = 5–6 dot blot experiments
shows that 9F3 reactivity was significantly re-
duced (p < 0.05), relative to D66 reactivity for
aggregates produced by control, H2O2 andNOR-3
incubations (data not shown).
(C) Transmission electron microscopy images of
purified tubulin aggregated in vitro under 72 hr
incubation in physiological buffer (control aggre-
gates), with H2O2, or with NOR-3 (data not shown).
Scale bar, 200 nm.To determine whether NCC-aggregated tubulin acts as a bona
fide cofactor/substrate for tPA-mediated plasmin formation
within the acutely injured brain, we subjected plasminogen/
mice and their wild-type littermates to TBI. It was anticipated
that absence of plasmin(ogen) would result in impaired clear-
ance of NCC aggregates following injury. Quantitative immu-
noblot analysis under reducing conditions showed that deter-
gent-insoluble b-tubulin significantly accumulated (by 154% at
24 hr post-TBI) in the ipsilateral cortex of wild-type mice
following TBI, whereas no accumulation of insoluble b-actin
was observed (Figure 6E). The abundance of detergent-insoluble
tubulin declined 48 hr post-TBI, suggesting that effective endog-
enous clearance mechanisms exist for these NCC-generated896 Cell Reports 2, 889–901, October 25, 2012 ª2012 The Authorsmisfolded proteins. As predicted, plas-
minogen-deficiency resulted in en-
hanced accumulation (by 230% at 24 hr
post-TBI) of detergent-insoluble tubulin
following TBI (Figure 6E). Therefore,
plasmin appears to be an aggregolytic
enzyme contributing to the clearance of
misfolded tubulin within the acutely
injured brain. We describe tubulin as an
injury-specific cofactor and substrate for
the tPA/plasmin system. This is particu-
larly noteworthy given that tubulin com-
prises24% of total protein in the brain
(Hiller and Weber, 1978). More im-
portantly, our data suggest that NCC
is a biological process governed by
efficient endogenous clearance mecha-nisms of which the tPA/plasmin system is one important
mechanism.
DISCUSSION
In the uninjured cytosol, proteins such as HSP90b, tubulin,
b-actin, and GAPDH exist as soluble noncovalently associated
multimers. Within the first few hours following injury, these
proteins remain soluble but relocate into two distinct cellular
structures: spheroids and somatic corpses. At a later point in
the cell death cascade, NCC occurs, whereby numerous cyto-
solic proteins associate into disulfide-crosslinked HMW deter-
gent-insoluble species. NCC coincides with complete loss of
cellular metabolism (Figure 1C), disturbed plasma membrane
integrity (Figures 1B and S5C), and exposure to tPA and other
extracellular ligands (Figures 6A and S5C). Thus, NCC occurs
upon end-stage cell death.
NCC represents a natural form of ‘‘fixation’’ that encapsulates
the nonviable nucleocytoplasm and axodendritic compart-
ments. To the best of our knowledge, these dead cell structures
have not been previously described in any biochemical detail.
Somatic corpses do, however, bear striking resemblance to
the electron-dense ‘‘incrusted’’ neurons from early ultrastructure
studies performed on injured brain tissue (Brown and Brierley,
1972; Hu et al., 2001; Kirino, 1982). Similarly, the described
spheroids are reminiscent of the axonal bulbs that develop after
TBI and are well-established sites of amyloid-b accumulation
(Uryu et al., 2007).
Prior studies show that injury with prooxidizing agonists trig-
gers disulfide bonding of selected intracellular proteins; notably
several of these studies identifiedmany of the same proteins that
participate in NCC (Bergemalm et al., 2010; Brennan et al., 2004;
Cumming et al., 2004; Cumming and Schubert, 2005; Eaton
et al., 2002; Huang et al., 2009; Kuhn et al., 2011; Nakajima
et al., 2007, 2009). The NCC proteins are also commonly gluta-
thionylated (Fratelli et al., 2002), S-nitrosylated (Jaffrey et al.,
2001), and oxidatively modified (Sultana et al., 2009) following
cellular stress. Thus, the proteins that undergo NCC harbor
highly reactive thiols and/or are especially vulnerable to free
radical damage. Importantly, all of these prior studies describe
protein modification and misfolding events within injured, but
nevertheless intact cells. The phenomenon of NCC temporally
supercedes these previously recognized protein modification
and misfolding events, as NCC occurs not during the initial
stages of cell injury, but upon end-stage cell death. This study
demonstrates that coordinated cell-wide disulfide crosslinking
of intracellular proteins is a hallmark and consequence of end-
stage cell death.
Characteristics of NCC
Using tubulin as a model to study NCC, we determined that
proteins entrapped in dead cell structures adopt many charac-
teristics of a misfolded protein: (1) detergent insolubility, (2)
accumulation into HMW species, (3) relocation into aberrant
cellular structures, (4) loss of native ‘‘9F3-reactive’’ state, and
(5) adopting a nonnative conformation.
One key feature of NCC is the nonamyloid nature of the
observed protein aggregation. Evidence for nonamyloid aggre-
gation was obtained from the amorphous morphology of
in vitro misfolded tubulin (Figure 5B). In addition, dead cell struc-
tures exhibited reactivity toward prefibrillar I11, but not toward
fibril-specific OC or LOC antibodies, denoting that NCC gener-
ates nonamyloid protein aggregates. In well-studied systems,
prefibrillar oligomeric species are short lived and rapidly prog-
ress into amyloid-like fibrillar species (Kayed et al., 2003).
Contrary to this pattern, the prefibrillar species generated by
NCC were readily detectable at 48 and 72 hr after injury with
no corresponding emergence of fibrillar species (Figure S4B).
Therefore, the prefibrillar species generated by NCC appear to
be kinetically stable, probably owing to their covalently cross-
linked architecture.CEnvironmental Causes of NCC
For disulfide crosslinking to be a driving force behind NCC,
a major change in intracellular redox status must occur. Proteo-
some dysfunction was not responsible for NCC, as no overt
accumulation of ubiquitinated proteins was observed following
glutamate or staurosporine exposure (Figure 1B), and neither
spheroids nor somatic corpses stained for lysine-48 polyubiqui-
tin (data not shown). Given that all tested forms of cell injury trig-
gered NCC, it seems that derailment of a fundamental cellular
parameter, such as plasma membrane integrity, instigates this
process. The reduced environment of the nucleocytoplasm nor-
mally prevents disulfide bond formation (Derman et al., 1993),
whereas the extracellular milieu is highly oxidizing and secreted
proteins typically contain disulfide bonds (Thornton, 1981). Thus,
loss of plasma membrane integrity would disturb the reduced
state of the nucleocytoplasm and trigger rapid disulfide cross-
linking of certain intracellular proteins. Although this sequence
of events is speculative, it does explain why NCC correlates
with LDH release (Figure 1C), with extracellular tPA binding
(Figures 6 and S5C; Samson et al., 2009), andwith cell-imperme-
able dye binding (Figures S1 and S5C; Samson et al., 2009).
Consequences of NCC
We predict that defects in the clearance mechanisms for NCC
predispose individuals to developing other proteinopathies. For
example, amyloid-b levels are regulated by tPA/plasmin activity
(Jacobsen et al., 2008; Ledesma et al., 2000; Sashindranath
et al., 2011) and tPA activity in the brain decreases with age,
which correlates with the risk of Alzheimer’s disease (Roussel
et al., 2009). In addition, TBI is a strong risk factor for sporadic
Alzheimer’s disease and other proteinopathies (Johnson et al.,
2010; Uryu et al., 2007). That GAPDH, tubulin and HSP90b are
prone to aggregation following TBI is of particular relevance as
these proteins are common components of senile plaques
(Liao et al., 2004; Wang et al., 2005).
We hypothesize that the nonamyloid nature of the misfolded
proteins generated by NCC favors physiological breakdown via
proteolysis, as opposed to amyloid deposits, which are difficult
to degrade. Indeed, significant reductions in misfolded tubulin
burden were evident in wild-type mice within 48 hr post-TBI,
suggesting that efficient clearance mechanisms exist for NCC.
Two other factors suggest that proficient clearance mechanisms
exist for NCC. First, the percentage of misfolded proteins was
much higher following injury in cell culture than in mice following
TBI, consistent with the notion that endogenous clearance
mechanisms operate in vivo. Indeed, the insoluble forms of the
identified proteins under injured conditions equated to <5% of
their soluble counterparts under uninjured conditions within the
adult mouse cortex (1.77% ± 0.37% of HSP90b, 4.33% ±
0.15% of b-tubulin and 2.39% ± 0.09% of GAPDH at 24 hr
post-TBI in wild-type mice; mean ± SEM; n = 4). Second, low
numbers of maleimide-positive cells were found in the lesion
24 hr post-TBI (Figure 3B), despite the high proportion of cell
death that has occurred within the ipsilateral cortex by this time.
Parallels between NCC and Blood Clot Removal
The processes of nucleocytoplasmic coagulation and the subse-
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Figure 6. Misfolded Tubulin Acts as a Cofactor/Substrate for Plasminogen Activation
(A) Addition of tPA555 and anti-b-tubulin D66 antibody to 48 hr-injured cultures shows that tPA binding colocalizes with tubulin on somatic corpses (arrows) and
spheroids (arrowheads). Micrographs are maximum projections of confocal xyz stacks. Scale bar, 10 mm.
(B) Representative immunoblots of reduced SDS-PAGE showing that plasmin generation on 48 hr-injured cultures decreased the amount of insoluble pelleted
tubulin.
(C) Collated amidolytic assay data showing that insoluble 72 hr H2O2-treated tubulin enhanced tPA-mediated plasminogen activation dramatically more than
soluble native tubulin. Data are mean ± SEM from n = 5 experiments.
(D) Representative Coomassie-stained reducing SDS-PAGE gel showing that tPA-mediated plasmin formation in vitro selectively degrades insoluble H2O2-
aggregated tubulin, but not soluble native tubulin.
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to conventional blood coagulation and fibrinolysis. The primary
purpose of blood coagulation is to restrict blood loss that is
achieved by the covalent crosslinking of fibrin monomers.
Hence, we postulate that NCC, like blood clotting, provides
a means of molecular containment that restricts the escape of
intracellular components upon end-stage cell death. Indeed,
the nuclei of dead cells were often encased in an intensely disul-
fide-bonded mesh of tubulin and other NCC proteins (Figures 3,
4, and S4). Following clot formation, the fibrinolytic system then
removes the fibrin scaffold via the recruitment of tPA and plas-
minogen. We have previously shown that tPA and plasminogen
interact with dead cells and fibrin via the same mechanisms,
and that the antifibrinolytic agents, tranexamic acid and aproti-
nin, selectively block plasmin-mediated degradation of dead
cells in vitro (Samson et al., 2009). Fibrin itself has been recently
described as amisfolded protein (Gebbink, 2011). Hence, akin to
fibrinolysis, we show that the macromolecular scaffold gener-
ated by NCC similarly recruits tPA and instigates its own
plasmin-mediated degradation (Figure 6).
The evidence to support a role for plasmin(ogen) in the
removal of NCC aggregates in vivo was obtained from
plasminogen/ mice where significantly elevated levels of mis-
folded b-tubulin were shown to accumulate in the brains of these
mice following TBI (Figure 6E). Plasminogen can be processed
into the angiogenesis inhibitor, angiostatin (O’Reilly et al.,
1994); however, as angiostatin is not a protease, it is unlikely
to be involved in clearance of NCC proteins. Instead, the most
likely explanation for the increased accumulation of aggregated
b-tubulin in the brains of plasminogen/ mice following TBI is
the inability of these mice to generate plasmin and initiate NCC
clearance. Since plasmin is a broad acting protease (Castellino
and Ploplis, 2005), we cannot formally rule out the possibility
that plasmin may be acting indirectly in vivo, for example, by
activating an intermediate protease that, in turn, cleaves aggre-
gated b-tubulin. However, our data strongly suggest that
plasmin plays a direct role in proteolytic breakdown of NCC
proteins. In particular, our in vitro data (Figures 6A–6D) show
that aggregated b-tubulin is a bona fide substrate for plasmin.
Furthermore, our prior studies show that dead neurons are the
foremost binding site for tPA ex vivo and efficiently drive
tPA-mediated plasmin formation and undergo direct plasmin-
mediated proteolytic breakdown (Samson et al., 2009). Collec-
tively our data are consistent with NCC clearance as not only
being a plasmin-mediated process, but also that NCC constitu-
ents are direct substrates for plasmin.
In conclusion, we describe NCC, a process that results from
a sudden change in the intracellular environment upon end-
stage cell death leading to rapid intermolecular disulfide cross-
linking and intracellular protein aggregation. We have observed
NCC following mechanistically distinct forms of injury in mouse
primary cortical neurons (Figure 1D), as well as upon cell death
of human lymphocytes (Figure 1E) and in vivo following trau-
matic brain injury (Figure 2B). Thus, we hypothesize that(E) Quantitative immunoblot analysis of detergent-insoluble proteins in the ip
plasminogen/ littermate mice (n = 3 per time point). Data are mean ± SEM.
between genotype and time post-TBI for b-tubulin (*p < 0.05).
See also Figure S5.
CNCC is a rudimentary event that affects diverse cell types irre-
spective of the cause of cell death. NCC is a natural form of
fixation that restricts the release of toxic intracellular compo-
nents and produces a misfolded protein corpse with a stable
and immunologically classifiable nonamyloid conformation
that accelerates tPA-mediated plasmin activation and dead
cell clearance. Distinct from the mechanism of plasmin-medi-
ated degradation, we find that NCC-generated plasmin also
increases the phagocytic removal of dead cells (R.J.B.,
A.L.S., A. Scholzen, M. Plebanski, and R.L.M., unpublished
data). Hence, we hypothesize that NCC generates a novel
damage-associated molecular pattern (DAMP). Like other
DAMPs, NCC aggregates represent a generic ‘‘altered-self’’
motif that tags dead cells and instructs clearance via the recruit-
ment and activation of humoral factors that promote dead cell
removal. NCC aggregates are likely to operate as a cofactor for
other extracellular enzymes that, like tPA, recognize misfolded
proteins and are activated at sites of injury (Maas et al., 2008).
Thus, we hypothesize that NCC generates a novel DAMP that
not only initiates proclearance mechanisms, but also serves as
a trigger for processes such as inflammation and tissue repair.
Additional in vivo and in vitro studies are needed to further dissect
the underlying mechanisms of NCC and to determine whether
NCCaggregates, like otherDAMPs, are important formaintaining
tissue homeostasis and preventing disease. Altogether, we
describe the process of NCC, a disulfide-driven protein aggrega-
tion event that has broad implications for trauma-associated
proteinopathies and host responses to cell death and acute
tissue injury.
EXPERIMENTAL PROCEDURES
Animals
All animal procedures were conducted in accordance with the Australian
National Health and Medical Research Council (NH&MRC) guidelines and
the Monash University Animal Ethics Committee. Experiments in Figures 2
and 3 were performed with adult male C57/Black6-J mice aged 8–12 weeks.
Experiments in Figure 6 were performed with adult plasminogen/ and plas-
minogen+/+ littermate mice aged 6–10 weeks (B6.129P2-Plgtm1Jld/J colony
obtained from Jackson Laboratories). Neuronal cultures were prepared from
E15 embryos dissected from pregnant C57/Black6-J mice aged 4–12 weeks.
Human Postmortem Brain Tissue
All procedures were conducted in accordance with the Australian NH&MRC
National Statement on Ethical Conduct in Human Research (2007), the Victo-
rian Human Tissue Act 1982, the National Code of Ethical Autopsy Practice,
and the Victorian Government Policies and Practices in Relation to Post
Mortem. Ethics approval was obtained from the Monash University Human
Research Ethics Committee. Clinical information of patients is included in
Table S2.
tPA Dialysis and Alexa Fluor 555 Conjugation
Dialysis/Alexa Fluor conjugation of tPA was performed as described (Samson
et al., 2009), with the modification that Alexa Fluor 555-conjugation was per-
formed in 0.35M HEPES-KOH (pH 7.4) and using the Alexa Fluor 555 micro-
scale protein labeling kit.silateral versus contralateral cortex of wild-type (n = 4 per time point) and
Two-way ANOVA with Bonferonni correction shows a significant relationship
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Cell Culture
Neuronal cultures was prepared as described (Samson et al., 2008). See
Extended Experimental Procedures for details. Injury was inflicted on cultures
that had been maintained for 6-8 days in vitro. To elicit injury, media was
replaced with phenol red-free Neurobasal media containing 2% (v/v) antioxi-
dant-free B27, 0.5 mM L-glutamine, 50 U/ml penicillin/streptomycin supple-
mented with the agonists: 200 nM staurosporine, 200 mM glutamate, 1 mM
MG132 or 6 mg/ml etoposide. Cultures were transfected with the BacMam2.0
baculovirus transfection reagent according to manufacturer’s instructions.
Jurkat cells were cultured under standard conditions (see also Extended
Experimental Procedures).
Cell Metabolism and Membrane Integrity Assays
Cell metabolism (dimethylthiazol-tetrazolium) and membrane integrity (lactate
dehydrogenase) assays were performed using commercially available kits
according to manufacturer’s instructions (see also Extended Experimental
Procedures).
Controlled Cortical Impact Model of TBI and Tissue Homogenization
CCI and tissue homogenization were performed as described (Sashindranath
et al., 2011). See also Extended Experimental Procedures.
Extraction of Triton-Soluble and Triton-Insoluble Fractions
Tissue homogenate (100 ml [7.5 mg]) was diluted into 900 ml of ice-cold PBS +
1% (v/v) Triton X-100. Sampleswere centrifuged (4C, 16,0003 g, 30min). The
supernatant was decanted and kept as the ‘‘Triton-soluble fraction.’’ The pellet
was washed in 1 ml of PBS + 1% (v/v) Triton X-100 and incubated for 1 hr with
gentle mixing at 25C in 60 ml of 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 5% glyc-
erol with or without 0.1M DTT. Samples were centrifuged (25C, 16,000 3 g,
30 min). The supernatant was decanted and kept as the ‘‘Triton-insoluble frac-
tion.’’ The pellet was washed in 1 ml of PBS + 1% Triton X-100 +1% SDS and
incubated for 10 min at 100C in 60 ml of 62.5 mM Tris-HCl (pH 6.8), 2% SDS,
5% glycerol, and 30% DMSO with or without 0.1M DTT. Samples were centri-
fuged (25C, 16,0003 g, 30 sec) and supernatant kept as the ‘‘pellet fraction.’’
Extraction of fractions from neuronal cultures was performed using the same
protocol except the starting material was 1 ml homogenate.
Immunofluorescence
Immunofluorescence was performed on paraformaldehyde-fixed, Triton-
permeabilized cultures. See also Extended Experimental Procedures.
Microscopy
All images were captured on a Zeiss Cell Observer system, a Nikon A1r-si
resonant scanning confocal system or an Olympus FV1000 MPE system.
See also Extended Experimental Procedures.
Maleimide Staining of Cultures
Paraformaldehyde-fixed cultures were washed twice in TBS + Triton (TBS-T)
and incubated in TBS-T + iodoacetamide overnight at 4C. Cultures were
washed in TBS-T, incubated in TBS-T ± DTT. Cultures were washed in
TBS-T, incubated in TBS-T + 100 nM Alexa Fluor 594-conjugated C5-
maleimide. Cultures were incubated in TBS + Hoechst 33342, washed in
TBS-T mounted in Fluorescent Mounting Medium (DAKO) and imaged. See
also Extended Experimental Procedures. A similar protocol was used for
maleimide staining of brain sections.
In-Gel Tryptic Digestion and Peptide Mass Fingerprinting
Procedures were using standard operating procedures of the Monash
Biomedical Proteomics facility (see also Extended Experimental Procedures).
Purified Tubulin In Vitro Aggregation and Analysis
Lyophilized porcine brain tubulin (97% pure) was reconstituted according
to the supplier’s instructions (Cytoskeleton Inc). In vitro aggregation was per-
formed in physiological PIPES buffer at 37C. See Extended Experimental
Procedures for details of dot blot, immunoblot, amidolytic, and cleavage
assays of purified tubulin aggregates.900 Cell Reports 2, 889–901, October 25, 2012 ª2012 The AuthorsElectron Microsopy
Images were obtained on a Hitachi H7500 transmission electron microscope
with an accelerating voltage of 80 kV. Samples were adsorbed onto
a carbon-coated grid and stained with 1% (w/v) uranyl acetate.
SDS-PAGE/Immunoblotting
Details regarding SDS-PAGE and Immunoblotting can be found in the
Extended Experimental Procedures.
Statistical Analyses
All results are based on three independent experiments unless stipulated.
Analyses were performed with GraphPad Prism 5.03 software. The statistical
analysis employed for each cohort is stated in the respective figure legend.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, two tables, and four movies and can be found with this article online
at http://dx.doi.org/10.1016/j.celrep.2012.08.026.
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